메뉴 건너뛰기




Volumn 314, Issue 19, 2015, Pages 2062-2068

Comparative risk of anaphylactic reactions associated with intravenous iron products

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS GLUCONATE; FERUMOXYTOL; IRON DEXTRAN; IRON SACCHARATE; FERRIC ION; FERRIC OXIDE, SACCHARATED; GLUCONIC ACID; MAGNETITE; SACCHARIC ACID;

EID: 84947431101     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.15572     Document Type: Article
Times cited : (177)

References (27)
  • 1
    • 84894067309 scopus 로고    scopus 로고
    • A systematic analysis of global anemia burden from 1990 to 2010
    • Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624.
    • (2014) Blood , vol.123 , Issue.5 , pp. 615-624
    • Kassebaum, N.J.1    Jasrasaria, R.2    Naghavi, M.3
  • 2
    • 84871051576 scopus 로고    scopus 로고
    • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
    • Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2163-2196
    • Vos, T.1    Flaxman, A.D.2    Naghavi, M.3
  • 3
    • 2342522079 scopus 로고    scopus 로고
    • Parenteral iron therapy options
    • Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol. 2004;76(1):74-78.
    • (2004) Am J Hematol , vol.76 , Issue.1 , pp. 74-78
    • Silverstein, S.B.1    Rodgers, G.M.2
  • 4
    • 84862649343 scopus 로고    scopus 로고
    • Parenteral versus oral iron therapy for adults and children with chronic kidney disease
    • Albaramki J, Hodson EM, Craig JC, Webster AC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012;1:CD007857.
    • (2012) Cochrane Database Syst Rev , vol.1 , pp. CD007857
    • Albaramki, J.1    Hodson, E.M.2    Craig, J.C.3    Webster, A.C.4
  • 5
    • 0034725897 scopus 로고    scopus 로고
    • Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation
    • Barton JC, Barton EH, Bertoli LF, Gothard CH, Sherrer JS. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. Am J Med. 2000;109(1):27-32.
    • (2000) Am J Med , vol.109 , Issue.1 , pp. 27-32
    • Barton, J.C.1    Barton, E.H.2    Bertoli, L.F.3    Gothard, C.H.4    Sherrer, J.S.5
  • 7
    • 0035057037 scopus 로고    scopus 로고
    • Suspected iron dextran-related adverse drug events in hemodialysis patients
    • Fletes R, Lazarus JM, Gage J, Chertow GM. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis. 2001;37(4):743-749.
    • (2001) Am J Kidney Dis , vol.37 , Issue.4 , pp. 743-749
    • Fletes, R.1    Lazarus, J.M.2    Gage, J.3    Chertow, G.M.4
  • 8
    • 84857592537 scopus 로고    scopus 로고
    • Comparison of rates of reported adverse events associated with IV iron products in the United States
    • Bailie GR. Comparison of rates of reported adverse events associated with IV iron products in the United States. Am J Health Syst Pharm. 2012;69 (4):310-320.
    • (2012) Am J Health Syst Pharm , vol.69 , Issue.4 , pp. 310-320
    • Bailie, G.R.1
  • 9
    • 0036233761 scopus 로고    scopus 로고
    • Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran
    • Ferrlecit Publication Committee
    • Michael B, Coyne DW, Fishbane S, et al; Ferrlecit Publication Committee. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002;61(5):1830-1839.
    • (2002) Kidney Int , vol.61 , Issue.5 , pp. 1830-1839
    • Michael, B.1    Coyne, D.W.2    Fishbane, S.3
  • 10
    • 0033981609 scopus 로고    scopus 로고
    • Parenteral iron use in the management of anemia in end-stage renal disease patients
    • Bailie GR, Johnson CA, Mason NA. Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis. 2000;35(1): 1-12.
    • (2000) Am J Kidney Dis , vol.35 , Issue.1 , pp. 1-12
    • Bailie, G.R.1    Johnson, C.A.2    Mason, N.A.3
  • 11
    • 0038777439 scopus 로고    scopus 로고
    • Safety in iron management
    • Fishbane S. Safety in iron management. Am J Kidney Dis. 2003;41(5)(suppl):18-26.
    • (2003) Am J Kidney Dis , vol.41 , Issue.5 , pp. 18-26
    • Fishbane, S.1
  • 14
    • 84886265620 scopus 로고    scopus 로고
    • Validation of anaphylaxis in the Food and Drug Administrations Mini-Sentinel
    • Walsh KE, Cutrona SL, Foy S, et al. Validation of anaphylaxis in the Food and Drug Administrations Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2013; 22(11):1205-1213.
    • (2013) Pharmacoepidemiol Drug Saf , vol.22 , Issue.11 , pp. 1205-1213
    • Walsh, K.E.1    Cutrona, S.L.2    Foy, S.3
  • 15
    • 31944443634 scopus 로고    scopus 로고
    • Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
    • Sampson HA, Muoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117(2):391-397.
    • (2006) J Allergy Clin Immunol , vol.117 , Issue.2 , pp. 391-397
    • Sampson, H.A.1    Muoz-Furlong, A.2    Campbell, R.L.3
  • 19
    • 0003729242 scopus 로고
    • The CollectedWorks of JohnW. Tukey VIII. Multiple Comparisons New York, NY Chapman &Hall
    • Tukey JW. The problem of multiple comparisons. In: The CollectedWorks of JohnW. Tukey VIII. Multiple Comparisons. New York, NY: Chapman &Hall; 1953.
    • (1953) The Problem of Multiple Comparisons
    • Tukey, J.W.1
  • 20
    • 79955045302 scopus 로고    scopus 로고
    • Clinical use of intravenous iron: Administration, efficacy, and safety
    • Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program. 2010;2010:338-347.
    • (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 338-347
    • Auerbach, M.1    Ballard, H.2
  • 21
    • 0034965685 scopus 로고    scopus 로고
    • A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo
    • Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant. 2001;16(6):1239-1244.
    • (2001) Nephrol Dial Transplant , vol.16 , Issue.6 , pp. 1239-1244
    • Kosch, M.1    Bahner, U.2    Bettger, H.3    Matzkies, F.4    Teschner, M.5    Schaefer, R.M.6
  • 22
    • 84904054374 scopus 로고    scopus 로고
    • A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD
    • Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol. 2014;9(4):705-712.
    • (2014) Clin J Am Soc Nephrol , vol.9 , Issue.4 , pp. 705-712
    • Macdougall, I.C.1    Strauss, W.E.2    McLaughlin, J.3    Li, Z.4    Dellanna, F.5    Hertel, J.6
  • 23
    • 26044476338 scopus 로고    scopus 로고
    • Hypersensitivity reactions and deaths associated with intravenous iron preparations
    • Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20(7):1443-1449.
    • (2005) Nephrol Dial Transplant , vol.20 , Issue.7 , pp. 1443-1449
    • Bailie, G.R.1    Clark, J.A.2    Lane, C.E.3    Lane, P.L.4
  • 25
    • 0033012811 scopus 로고    scopus 로고
    • Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
    • Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33(3): 464-470.
    • (1999) Am J Kidney Dis , vol.33 , Issue.3 , pp. 464-470
    • Faich, G.1    Strobos, J.2
  • 26
    • 84879840410 scopus 로고    scopus 로고
    • Ferumoxytol: A silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
    • Pai AB, Garba AO. Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud? J Blood Med. 2012;3:77-85.
    • (2012) J Blood Med , vol.3 , pp. 77-85
    • Pai, A.B.1    Garba, A.O.2
  • 27
    • 84947478465 scopus 로고    scopus 로고
    • FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol Updated April 2 2015 Accessed September 13, 2015
    • FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm. Updated April 2, 2015. Accessed September 13, 2015.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.